NCT05358158Completed
Chest dRain rEmoval intrAoperatively afTer thoracOscopic Wedge Resection
Efficacy of Avoiding Chest Drain After Video-assisted Thoracoscopic Surgery Wedge Resection
Source: ClinicalTrials.gov · Last updated 20 Mar 2024
Brief summary (registry, in English)
Chest drain is used routinely after lung surgery. Despite preliminary studies demonstrate the feasibility and safety of intraoperative chest drain removal, these are either retrospective or mainly concerning benign disease. Hypothesis: Participants treated without post-operative chest tube after thoracoscopic wedge resection have less pain, reduced opioid usage without increasing postoperative complications than participants treated with standard post-operative chest tube, and could possibly be discharged earlier.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 94 (actual)
- First submitted
- 28 Apr 2022
- Start date
- 4 May 2022
- Primary completion date
- 17 Mar 2024
- Lead sponsor
- Copenhagen University Hospital, Rigshospitalet
- Diseases
- Lung cancer
- NCT number
- NCT05358158
What you commit to
- Study type: Interventional
- Participants enrolled: 94
- From 4 May 2022 to the primary completion date, 17 Mar 2024
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Increased risk of post-operative air leak assessed perioperatively by the surgeon (e.g. severe adhesions, bullous/emphysematous lung tissue, defects of the visceral pleura due to iatrogenic or other reasons, suturing in the lung tissue, deep lung resection).
Other illness
- Increased risk of post-operative bleeding assessed perioperatively by the surgeon (e.g. intraoperative bleeding or oozing).
Other
- Air leak during intraoperative air leak test.
Who the study is looking for
- Age ≥18 years.
- Patients referred for elective three port video-assisted thoracoscopic surgery wedge resection of the lung for suspected or confirmed malignant nodules.
- first second forced expiratory volume ≥60% of expected.
- No increased bleeding risk (e.g. preoperative international normalized ratio \>2, overdue discontinuation of anticoagulants according to guidelines by the Danish Society for Thrombosis and Haemostasis, known coagulopathy).
- Not scheduled for frozen section pathology of wedge resection and subsequent lobectomy.
- Able and willing to give informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Thomas Decker Christensen Coordinator of this site? Confirm its status | Aarhus | Denmark | Unknown status |
| Rigshospitalet Coordinator of this site? Confirm its status | Copenhagen | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.